CompletedNot Applicable

To Compare "Balloon Occluded Thrombolysis" With "Conventional Catheter Directed Thrombolysis" in Thrombotically Occluded DIPSS Stent in Patients of Budd- Chiari Syndrome.

India33 participantsStarted 2021-11-05

Plain-language summary

DIPSS has become a widely accepted treatment for complications of portal hypertension. Shunt or hepatic vein stenosis are common short and mid term complications of the procedure. When identified early, shunt stenosis or occlusion may be treated before recurrence of the symptoms for which DIPSS was done at the first place. Present day endovascular DIPSS revision techniques have significantly improved the primary assisted patency rates. The purpose of this study is to understand the newer technique of Combined balloon occlusion thrombolysis and intra stent balloon sweeping being practiced at our institute and compare it with the widely used conventional thrombolytic methods.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients of Budd- Chiari syndrome who underwent DIPSS revision for blocked stent till February 2021

Exclusion criteria

✕. Patients who underwent DIPSS revision more than one time using both the techniques were excluded.
✕. Failure to cannulate existing shunt.

What they're measuring

Compare the rate of re-stenting between the two groups

Timeframe: Day 0

Compare the mean total dose of thrombolytic drug administered between the two groups

Timeframe: Day 0

Trial details

NCT IDNCT05117684

SponsorInstitute of Liver and Biliary Sciences, India

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-20

View on ClinicalTrials.gov More Budd-Chiari Syndrome trials